Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04811313

Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy

Impact of Tranexamic Acid Use on Blood Loss and Transfusion Rates After Hip Reconstruction in Children, A Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

Surgical hip reconstruction reduces the hip joint through soft tissue releases and osteotomies of the femur and/or pelvis. Blood loss and subsequent blood transfusion are normal consequences of hip reconstruction.

Detailed description

the use of antifibrinolytics (AFs) to limit blood loss peri-operatively has been popularized in certain subspecialties. AFs have been studied extensively in adults undergoing various orthopedic procedures including spine and total joint arthroplasty, and have been proven to reduce blood loss and reduce the risk of blood transfusion. Similarly, AFs are used in pediatric patients undergoing cardiac surgery as well as craniofacial operations. Tranexamic acid (TXA) is a synthetic anti-fibrinolytic agent that works by reversibly blocking plasminogen and thereby promoting hemostasis through the prevention of fibrin degradation. Current literature investigating the safety and effectiveness of TXA in children undergoing orthopedic procedures is limited. We hypothesize that patients treated with TXA will have reduced blood loss and transfusion requirements compared with those who did not receive TXA.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic acidpatients treated with TXA will have reduced blood loss and transfusion requirements compared with those who did not receive TXA
PROCEDUREcaudal epidural blockregional anesthesia in orthopedic procedures are known to help reduction of intraoperative blood loss
OTHERPlaceboparticipants will receive standard care but neither TXA nor caudal epidural block

Timeline

Start date
2025-04-03
Primary completion
2026-01-01
Completion
2026-03-01
First posted
2021-03-23
Last updated
2025-11-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04811313. Inclusion in this directory is not an endorsement.